Table 2.
Assessment of the cardiac structure and function in patients before and after RDN.
| Detection indexes | Patients | ||
|---|---|---|---|
| Baseline (n = 190) | 6 months (n = 184) | 12 months (n = 176) | |
| SBP (mmHg) | 156.38 ± 11.36 | 133.57 ± 8.56∗∗∗ | 135.24 ± 7.27∗∗∗ |
| DBP (mmHg) | 99.55 ± 9.71 | 86.71 ± 6.68∗∗ | 85.61 ± 5.16∗∗ |
| MAP (mmHg) | 118.50 ± 9.87 | 102.33 ± 7.67∗∗ | 102.15 ± 6.87∗∗ |
| HR (bpm) | 94.33 ± 5.63 | 78.84 ± 6.36∗∗∗ | 79.37 ± 7.15∗∗∗ |
| NT-proBNP (pg/ml) | 458.67 ± 10.33 | 216.64 ± 9.75∗∗∗ | 221.69 ± 11.49∗∗∗ |
| E/A | 1.06 ± 0.06 | 1.07 ± 0.08 | 1.03 ± 0.06 |
| E/e′ | 17.23 ± 1.21 | 11.23 ± 1.03∗∗∗ | 10.17 ± 1.09∗∗∗ |
| e′ (cm/s) | 5.77 ± 0.64 | 8.43 ± 0.84∗∗∗ | 7.27 ± 0.76∗∗∗ |
Values are given in the form of mean ± SD. ∗∗P < 0.001; ∗∗∗P < 0.001 versus the baseline group.